News
News Flash: Memory Shop and Anime Zakka to Open in Harvard Square
News
Harvard Researchers Develop AI-Driven Framework To Study Social Interactions, A Step Forward for Autism Research
News
Harvard Innovation Labs Announces 25 President’s Innovation Challenge Finalists
News
Graduate Student Council To Vote on Meeting Attendance Policy
News
Pop Hits and Politics: At Yardfest, Students Dance to Bedingfield and a Student Band Condemns Trump
In its first performance this year open to the public, the 47 Workshop will produce three one-act plays in the Agassiz Theatre, Radcliffe College, at 2 o'clock this afternoon. An evening performance will also be given at 8 o'clock this evening. The entire proceeds from the sale of tickets will be devoted to the Radcliffe Red Cross Auxiliary. The departure from the usual private performances was made with this purpose in view.
The three plays to be presented are written, acted and managed by students in Professor Baker's English 47 course, and are being produced under his direction. The names of the plays are "The Simms-Vane Incident," "Three Pills in a Bottle" and "The Good Men Do."
The cast of "The Simms-Vane Incident," written by J. E. Pillot Sp., is as follows: Second Play by Miss Rachel Field. The second play will be "Three Pills in a Bottle," by Miss Rachel Lyman Field, a graduate student at Radcliffe. The parts will be taken as follows: The third play, entitled "The Good Men Do," was written by Hubert Osborne, Sp., the holder of the MacDowell Fellowship awarded in Dramatic Composition.
Second Play by Miss Rachel Field.
The second play will be "Three Pills in a Bottle," by Miss Rachel Lyman Field, a graduate student at Radcliffe. The parts will be taken as follows: The third play, entitled "The Good Men Do," was written by Hubert Osborne, Sp., the holder of the MacDowell Fellowship awarded in Dramatic Composition.
The third play, entitled "The Good Men Do," was written by Hubert Osborne, Sp., the holder of the MacDowell Fellowship awarded in Dramatic Composition.
Want to keep up with breaking news? Subscribe to our email newsletter.